Advances in obesity therapy: Innovative medications in development

Obesity is a multifactorial condition characterized by an energy imbalance, which can be attributed to excessive consumption of high-calorie foods, reduced energy expenditure, and predisposing genetic factors. This combination of factors contributes to excessive body fat accumulation, leading to structural and functional changes in the body. Such changes are associated with significant health risks, debilitating complications, high morbidity and mortality rates, and a negative impact on individuals’ quality of life. Innovative approaches to obesity treatment include a combination of pharmacological therapies, behavioral interventions, and medical devices aimed at improving weight control and patients’ metabolic health. This article aims to provide an overview of innovative approaches in obesity treatment, addressing pharmacological therapies, behavioral interventions, and the use of innovative medical devices. A literature review was conducted through a comprehensive search in scientific databases, including PubMed, Scielo, LILACS, and Google Scholar, focusing on articles published in the last five years. Notably, advanced-stage therapies such as immunotherapy, which aims to modulate immune responses associated with weight gain, gene therapy, which seeks to correct genetic predispositions related to obesity, and modulation of the gut microbiota, which has shown potential in regulating metabolism and improving lipid profiles, are highlighted. The combination of these approaches, integrated in a personalized and targeted manner, represents a significant advancement in obesity treatment, providing more effective, sustainable, and tailored therapeutic solutions to meet patients’ individual needs, with a positive impact on quality of life and the prevention of complications associated with this condition.